Best AI Medical Diagnostic Platforms - Page 7

How Many AI Medical Diagnostic Platforms Products Does G2 Track?

Total Products under this Category: 118

Category Stats (Nov 2026)

  • Average Rating: 4.4/5 (↓0.23 vs Oct 2026) The average rating of products in this category, based on all submitted ratings
  • Top Trending Product: myExam Companion (+8.75%) - Among all products in this category, myExam Companion recorded the largest rating increase compared to last month

Last updated: November 13, 2026

How Does G2 Rank AI Medical Diagnostic Platforms Products?

Why You Can Trust G2's Software Rankings:

  • 30 Analysts and Data Experts
  • 300+ Authentic Reviews
  • 118+ Products
  • Unbiased Rankings

G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.

G2 Grid® for AI Medical Diagnostic Platforms

G2 Grid® for AI Medical Diagnostic Platforms plotting products by satisfaction and market presence

Highlighted products: OpenEvidence, PathAI, Viz.ai One, MR SmartSpeed, 5C Network, Deep Resolve, Qure AI, and Lunit.

Underlying data: [Grid® JSON](https://www.g2.com/categories/ai-medical-diagnostic-platforms/grids.json?focus%5B%5D=openevidence&focus%5B%5D=pathai&focus%5B%5D=viz-ai-one&focus%5B%5D=mr-smartspeed&focus%5B%5D=5c-network&focus%5B%5D=deep-resolve&focus%5B%5D=qure-ai-2022-07-05&focus%5B%5D=lunit)

Neuro Event Labs

Neuro Event Labs, founded in 2015 in Tampere, Finland, specializes in AI-driven diagnostic solutions for epilepsy management. Their flagship product, Nelli®, is a non-contact, AI-powered seizure monitoring system that utilizes video and audio recordings to detect and analyze motor seizures. Designed for use both at home and in hospital settings, Nelli® provides healthcare professionals with objective, high-quality data to enhance diagnosis and treatment decisions for epilepsy patients. Key Features and Functionality: - Non-Invasive Monitoring: Nelli® employs a Personal Recording Unit (PRU) equipped with a camera and microphone to capture video and audio data without the need for wearable devices, ensuring patient comfort. - AI-Powered Analysis: Advanced machine learning algorithms process the recorded data to identify and prioritize seizure events with positive motor components, facilitating efficient review by healthcare professionals. - Interactive Reporting: The system generates interactive reports accessible via a web-based dashboard, allowing physicians to review detected events, assess seizure patterns, and make informed treatment decisions. - Regulatory Approvals: Nelli® is CE-marked as a Class I medical device under Directive 93/42/EEC and has received Breakthrough Device Designation from the U.S. FDA, highlighting its innovative approach to seizure monitoring. Primary Value and User Benefits: Nelli® addresses the critical need for accurate and continuous seizure monitoring, particularly during periods of rest when seizures often go unnoticed. By providing objective, reliable data on seizure frequency and characteristics, Nelli® enables healthcare providers to tailor treatment plans more effectively, potentially increasing the likelihood of patients achieving seizure freedom. Its non-invasive design enhances patient compliance, while the AI-driven analysis reduces the burden on medical staff, leading to improved patient outcomes and more efficient clinical workflows.

Who Is the Company Behind Neuro Event Labs?

Nuclivision

Nuclivision is a Ghent-based medtech startup founded in 2022, specializing in AI-driven solutions to enhance nuclear medicine practices. Their flagship product, Nuclarity, is an advanced software platform designed to improve the efficiency and safety of PET (Positron Emission Tomography) imaging. By leveraging state-of-the-art AI algorithms, Nuclarity enables significant reductions in both scan times and the required doses of radioactive tracers, all while maintaining high diagnostic accuracy. This innovation addresses critical challenges in nuclear medicine, such as patient safety concerns, operational inefficiencies, and the growing demand for timely diagnostic procedures. Key Features and Functionality: - AI-Powered Image Enhancement: Nuclarity utilizes advanced deep learning techniques to enhance PET scan images, ensuring high-quality diagnostics even with reduced scan times and lower radiotracer doses. - Dose and Time Reduction: The software allows for up to a 50% reduction in both the administered radioactive dose and the duration of PET scans, minimizing radiation exposure and improving patient safety. - Seamless Integration: Nuclarity integrates smoothly with existing clinical workflows through the Nuclivision Gateway, facilitating easy adoption without disrupting current operations. - Scalability: Designed to meet the increasing demand for PET imaging, Nuclarity enhances scanner efficiency, enabling faster scheduling and better utilization of imaging resources. Primary Value and User Solutions: Nuclarity addresses several pressing issues in nuclear medicine: - Enhanced Patient Safety: By reducing radiation exposure, the software mitigates associated health risks, making PET scans safer for patients, particularly in pediatric cases and for those requiring repeated imaging. - Operational Efficiency: Shorter scan times and lower radiotracer usage lead to increased patient throughput and reduced operational costs, allowing imaging centers to handle higher volumes without compromising quality. - Improved Accessibility: The efficiency gains and safety improvements make PET imaging more accessible, addressing the growing demand for timely diagnostics in oncology and neurology. In summary, Nuclivision's Nuclarity revolutionizes PET imaging by combining AI-driven image enhancement with operational efficiencies, resulting in faster, safer, and more accessible nuclear medicine diagnostics.

Who Is the Company Behind Nuclivision?

Olli Health

Olli Health is a healthtech company that offers AI-powered home health coding & OASIS QR.

Who Is the Company Behind Olli Health?

AI can help you find the answers. G2 helps you trust them.

Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.

How it works
Connect G2 to ChatGPTConnect G2 to Claude

PediaMetrix

PediaMetrix brings AI and computer vision to pediatric health to lower cost and improve outcome.

Who Is the Company Behind PediaMetrix?

Peerbridge Health

Peerbridge Health offers a wearable ECG platform that uses AI to detect heart failure, sleep apnea, and ejection fraction changes.

Who Is the Company Behind Peerbridge Health?

PeriVision

Perivision offers cloud computing, virtual reality, and artificial intelligence to create next-generation solutions.

Who Is the Company Behind PeriVision?

PictorLabs

PictorLabs is a digital pathology company specializing in AI-powered virtual staining technology designed to transform histopathology and expedite clinical research, ultimately aiming to enhance patient outcomes. By applying deep learning algorithms, PictorLabs' platform can generate virtual stains from a single unstained tissue sample, producing results that are indistinguishable from traditional chemical stains. This innovation streamlines laboratory workflows, reduces turnaround times, and minimizes the use of chemical reagents, contributing to more sustainable laboratory practices.

Who Is the Company Behind PictorLabs?

Play Health

Play Health is a comprehensive care platform designed to support women navigating perimenopause and menopause. By integrating at-home hormone testing, real-time symptom tracking, and AI-driven personalized guidance, Play Health empowers users to manage their health transitions effectively. The platform connects patient-specific data to a clinician dashboard, providing the longitudinal context needed for more confident and proactive care. Key Features and Functionality: - At-Home Hormone Testing: Enables users to measure key hormones linked to perimenopause symptoms through simple, painless at-home sample collection, with clinical-grade lab analysis and personalized results. - Symptom and Cycle Tracking: Allows users to log symptoms, sleep patterns, mood changes, and menstrual cycle variations, creating a detailed health record. - AI-Powered Personalized Guidance: Utilizes AI to analyze collected data, offering tailored health insights and care protocols to address individual needs. - Clinician Dashboard Integration: Shares user data with healthcare providers through a secure dashboard, facilitating informed discussions and collaborative care decisions. Primary Value and User Solutions: Play Health addresses the often-overlooked complexities of perimenopause and menopause by providing measurable, trackable, and manageable health data. By offering tools for at-home hormone testing and comprehensive symptom tracking, the platform demystifies these life stages, enabling women to take control of their health with confidence. The integration with healthcare providers ensures that users receive personalized, evidence-based care, reducing the risk of misdiagnosis and enhancing overall well-being.

Who Is the Company Behind Play Health?

Potrero Medical

Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence.

Who Is the Company Behind Potrero Medical?

PRAID AI

PRAID AI is an advanced diagnostic platform that integrates radiology, pathology, and microscopy into a unified AI-powered ecosystem. Designed to enhance early disease detection, it enables clinicians to identify cancers and other diseases more swiftly and accurately. By digitizing medical data and providing actionable insights, PRAID AI streamlines diagnostic workflows, reducing delays and improving patient care. Key Features and Functionality: - Radiology Integration: Utilizes AI-driven image analysis to expedite and refine the interpretation of medical scans, minimizing diagnostic delays and boosting confidence. - Pathology Insights: Offers automated analysis of tissue samples and pathology slides, aiding in the early detection of complex patterns with heightened precision. - Microscopy Connectivity: Integrates advanced microscopy to link cellular-level insights with broader imaging, providing a comprehensive view of disease progression. - Vision-Language Model (VLM): Employs multimodal AI to interpret images and generate automated, meaningful diagnostic reports. - Annotation Tools: Provides AI-powered annotation capabilities for radiology and pathology, accelerating labeling processes and enhancing accuracy for both clinical and research applications. - Collaborative Dashboard: Features a unified interface for radiologists, pathologists, and clinicians to review, compare, and collaborate on patient cases in real time. Primary Value and Problem Solved: PRAID AI addresses the critical need for faster and more accurate disease detection by unifying multiple diagnostic disciplines into a single platform. This integration reduces diagnostic turnaround times by up to 40%, cuts costs by approximately 35%, and enhances overall diagnostic accuracy. By automating routine tasks and providing AI-assisted insights, PRAID AI allows healthcare professionals to focus more on patient care, ultimately leading to improved outcomes and increased clinician satisfaction.

Who Is the Company Behind PRAID AI?

Predicta Biosciences

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

Who Is the Company Behind Predicta Biosciences?

Prenosis

Prenosis is a health technology innovator leveraging AI and machine learning to deliver precision diagnostics in acute care, notably for sepsis. Their FDA-authorized Sepsis ImmunoScore utilizes clinical and biomarker data to provide an on-demand risk assessment, enabling earlier diagnosis and treatment to improve patient outcomes and reduce healthcare costs.

Who Is the Company Behind Prenosis?

  • Seller: Prenosis
  • Year Founded: 2014
  • HQ Location: Chicago, US
  • LinkedIn® Page: www.linkedin.com
    38 employees on LinkedIn®

Quanzhentong

Quanzhentong specializes in medical AI products and services, utilizing its comprehensive platform in numerous hospitals.

Who Is the Company Behind Quanzhentong?

Radiolife

Radiolife is a deep-tech diagnostics company developing a next-generation, reagent-less pathogen detection platform powered by radio frequency (RF) signal analysis and artificial intelligence. Our mission is to make diagnostics faster, more accessible, and dramatically more scalable by replacing traditional chemistry-dependent workflows with advanced physics-based sensing and machine learning. At the core of our technology is Cube Scan™, a compact AI-driven diagnostic device capable of analyzing liquid samples in seconds without the need for reagents, cartridges, or complex laboratory infrastructure. By capturing RF signal patterns across biological samples and processing them through proprietary machine learning models, Radiolife can identify unique molecular and microbial signatures associated with pathogens and biomarkers. Unlike conventional diagnostics that rely on PCR amplification, antibodies, or culture growth, Radiolife’s platform is designed to deliver rapid, low-cost, and highly scalable testing with minimal operational complexity. This enables applications across infectious disease diagnostics, veterinary health, food safety, environmental monitoring, and biodefense preparedness. Radiolife has already demonstrated strong preclinical performance across multiple use cases, including E. coli detection and arbovirus screening for dengue, chikungunya, and oropouche, achieving accuracy rates above 90% in funded studies. The company is also advancing programs focused on Highly Pathogenic Avian Influenza (HPAI) detection in poultry and biomarker analysis for inflammatory diseases. Our work has been supported by organizations and programs including BARDA, the USDA, NVIDIA Inception, AWS, Northeastern University’s Institute for Experiential AI, and the Roux Institute. Radiolife was also selected for the USDA HPAI Poultry Innovation Grand Challenge and received non-dilutive funding through the BARDA Accelerator Network. By combining AI diagnostics, RF biosensing, and reagent-free testing into a single portable platform, Radiolife is building a future where high-precision diagnostics can be deployed anywhere — from advanced laboratories to farms, clinics, airports, and remote communities worldwide.

Who Is the Company Behind Radiolife?

Renalytix AI

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

Who Is the Company Behind Renalytix AI?

Emma Stein
ES
Researched and written by Emma Stein
Updated October 21, 2026